News

A scientific team has engineered a COVID-19 vaccine that induced – in pre-clinical models – very long-lasting, protective immunity against SARS-CoV-2 virus with a single-shot immunisation.

A study from the University of Michigan Health reveals a connection between the most common type of white blood cells, which act as a first defense in the body’s immune system, and a severe complication of CAR T-Cell immunotherapy.

Human monoclonal antibodies against influenza B may help to fight the virus in the elderly and immunocompromised.

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals’ immune systems to induce rare precursor B cells of a class of HIV broadly neutralizing antibodies (bNAbs).

A consortium of scientists have developed a promising new human monoclonal antibody that appears a step closer to a universal antibody cocktail that works against all strains of SARS-CoV-2.

An Oregon Health & Science University-developed platform for cytomegalovirus-based vaccines shows promise as a “shield” against cancer. OHSU researchers used CMV to transport cancer-related antigens that would cause an immune response.

An interdisciplinary collaboration has designed a way to “cloak” proteins so that they can be captured by lipid nanoparticles, which are akin to tiny bubbles of fat.

Vaccination remains the most effective strategy for avian influenza prevention and control in humans, despite varying vaccine efficacy across strains.

An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in preclinical models.

A substance naturally occurring in i.a. pomegranates, strawberries and walnuts can improve memory and treatment of Alzheimer’s disease, a new study conducted at the University of Copenhagen concludes.